What buyback of shares mean
Buyback of shares refers to a corporate action where a company repurchases its own shares from the existing shareholders. Usually, the company purchases the shares at a higher price than the current levels, encouraging investors to participate. Typically, a company decides to buy back its shares in order to increase share value, utilise surplus cash, prevent hostile takeovers or to increase promoter holdings.
Recent tax changes for share buyback
Finance Bill 2026 introduced a uniform 12% surcharge on capital gains from share buybacks, but this applies only to promoters. According to JM Financial, this will likely affect company founders, key directors, controlling shareholders and others. In the case of non-promoter shareholders, however, surcharges shall continue to be governed by the normal applicable provisions, depending on the overall income profile.
Wipro buyback
Wipro last week announced that its board will consider a buyback of shares along with its results for the January-March quarter of FY26 on April 16 (Thursday). While details such as the size of the buyback, price and route have not yet been disclosed, the move signals potential capital allocation action by the company at a time when sentiments in IT stocks volatile. Wipro had last announced a share buyback in 2020. If approved tomorrow, the buyback would mark the fifth such action taken by the IT services major so far.
Aurobindo Pharma buyback
Aurobindo Pharma approved a share buyback worth Rs 800 crore on April 6, with the record date being set at April 17 (Friday). The buyback price was fixed at Rs 1,475 apiece, which marks a premium of more than 10% from the stock’s previous closing price of Rs 1,339.80 apiece on NSE. The repurchase will be carried out through the tender offer route. This marks the company’s second buyback in less than two years.
Windlas Biotech
Windlas Biotech on Tuesday said that its board of directors will consider and approve the proposal to buy back its shares during a board meeting scheduled for April 17 (Friday). If approved, this would mark the first-ever buyback announced by the domestic pharmaceutical formulations contract development and manufacturing organization (CDMO).
Cyient buyback
Cyient on Tuesday said that its board of directors will meet on April 23 (Thursday) to consider and approve the proposal for buyback of shares of the company, along with a final dividend for the financial year 2026 and Q4 earnings. If approved, this would mark the first-ever share buyback announced by the tech company.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)